Cargando…

Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes

AIMS/HYPOTHESIS: Type 2 diabetes mellitus is associated with reduced incretin effects. Although previous studies have shown that hyperglycaemia contributes to impaired incretin responses in beta cells, it is largely unknown how hyperlipidaemia, another feature of type 2 diabetes, contributes to impa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Z. F., Deng, Y., Zhou, Y., Fan, R. R., Chan, J. C. N., Laybutt, D. R., Luzuriaga, J., Xu, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536946/ https://www.ncbi.nlm.nih.gov/pubmed/23188390 http://dx.doi.org/10.1007/s00125-012-2776-x

Ejemplares similares

Incretin Receptor Null Mice Reveal Key Role of GLP-1 but Not GIP in Pancreatic Beta Cell Adaptation to Pregnancy
por: Moffett, R. Charlotte, et al.
Publicado: (2014)

Increased NEFA levels reduce blood Mg(2+) in hypertriacylglycerolaemic states via direct binding of NEFA to Mg(2+)
por: Kurstjens, Steef, et al.
Publicado: (2018)

GIP and GLP‐1, the two incretin hormones: Similarities and differences
por: Seino, Yutaka, et al.
Publicado: (2010)

GLP-1R Signaling and Functional Molecules in Incretin Therapy
por: Wan, Wenwei, et al.
Publicado: (2023)

Molecular Pharmacology of the Incretin Receptors
por: Al-Sabah, Suleiman
Publicado: (2016)

Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
por: Marathe, Chinmay S., et al.
Publicado: (2011)

From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
por: Holst, Jens Juul
Publicado: (2019)

A Physiologically‐Based Quantitative Systems Pharmacology Model of the Incretin Hormones GLP‐1 and GIP and the DPP4 Inhibitor Sitagliptin
por: Balazki, Pavel, et al.
Publicado: (2020)

The Incretin Effect in Female Mice With Double Deletion of GLP-1 and GIP Receptors
por: Ahrén, Bo, et al.
Publicado: (2019)

Intrahepatic Lipid Content and Insulin Resistance Are More Strongly Associated with Impaired NEFA Suppression after Oral Glucose Loading Than with Fasting NEFA Levels in Healthy Older Individuals
por: Finucane, Francis M., et al.
Publicado: (2013)

Incretin-Modulated Beta Cell Energetics in Intact Islets of Langerhans
por: Hodson, David J., et al.
Publicado: (2014)

Modulation of Adipocytokines Production and Serum NEFA Level by Metformin, Glimepiride, and Sitagliptin in HFD/STZ Diabetic Rats
por: Saad, Mohamed I., et al.
Publicado: (2015)

A Critical Analysis of the Clinical Use of Incretin-Based Therapies : Are the GLP-1 therapies safe?
por: Butler, Peter C., et al.
Publicado: (2013)

GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics
por: Wright, Shane C., et al.
Publicado: (2023)

Quantitative and qualitative analyses of human salivary NEFA with gas-chromatography and mass spectrometry
por: Kulkarni, Bhushan V., et al.
Publicado: (2012)

Considerations about the in situ derivatization and fractionation of EFA and NEFA in biological and food samples
por: Pimentel, Lígia L., et al.
Publicado: (2015)

NEFAs Influence the Inflammatory and Insulin Signaling Pathways Through TLR4 in Primary Calf Hepatocytes in vitro
por: Deng, Qinghua, et al.
Publicado: (2021)

The Impact of Low-dose Gliclazide on the Incretin Effect and Indices of Beta-cell Function
por: Cordiner, Ruth L M, et al.
Publicado: (2021)

The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists
por: van Baar, Michaël J. B., et al.
Publicado: (2019)

NEFA Promotes Autophagosome Formation through Modulating PERK Signaling Pathway in Bovine Hepatocytes
por: Huang, Yan, et al.
Publicado: (2021)

Degradation of the Incretin Hormone Glucagon-Like Peptide-1 (GLP-1) by Enterococcus faecalis Metalloprotease GelE
por: LeValley, Stephanie L., et al.
Publicado: (2020)

Effects of Hormone, NEFA and SCFA on the Migration of Neutrophils and the Formation of Neutrophil Extracellular Traps in Dairy Cows
por: Lv, Guanxin, et al.
Publicado: (2022)

Pharmacological antagonism of the incretin system protects against diet-induced obesity
por: Svendsen, Berit, et al.
Publicado: (2019)

The potential role of incretin therapy in the hospital setting
por: Macdonald, Jennifer J., et al.
Publicado: (2015)

Macroalgal protein hydrolysates from Palmaria palmata influence the ‘incretin effect’ in vitro via DPP-4 inhibition and upregulation of insulin, GLP-1 and GIP secretion
por: McLaughlin, C. M., et al.
Publicado: (2021)

Failure of the Adaptive Unfolded Protein Response in Islets of Obese Mice Is Linked With Abnormalities in β-Cell Gene Expression and Progression to Diabetes
por: Chan, Jeng Yie, et al.
Publicado: (2013)

Chylomicrons stimulate incretin secretion in mouse and human cells
por: Psichas, Arianna, et al.
Publicado: (2017)

Mulberry leaf alleviates streptozotocin-induced diabetic rats by attenuating NEFA signaling and modulating intestinal microflora
por: Sheng, Yao, et al.
Publicado: (2017)

Autocrine negative feedback regulation of lipolysis through sensing of NEFAs by FFAR4/GPR120 in WAT
por: Husted, Anna Sofie, et al.
Publicado: (2020)

NEFA, BHBa, UREA and Liver Enzyme Variation in the Bloodstream of Weaned Foals up to 18 Months of Age
por: Cappai, Maria Grazia, et al.
Publicado: (2021)

Clustering and Correlations amongst NEFA, Selected Adipokines and Morphological Traits—New Insights into Equine Metabolic Syndrome
por: Daradics, Zsofia, et al.
Publicado: (2022)

NEFA Dynamics in Adults With Severe Obesity and Insulin Resistance: No Coupling to the rs9939609 FTO Risk Allele
por: Mostad, Ingrid Løvold, et al.
Publicado: (2023)

Pancreatitis Associated With Incretin-Based Therapies
por: Iyer, Shridhar N., et al.
Publicado: (2013)

Incretin Concepts
por: Bloomgarden, Zachary T.
Publicado: (2010)

Inflammation and incretins
por: Hatwal, Amitabh
Publicado: (2012)

Incretins in the ICU: is insulin on its way out?
por: Kovalaske, Michelle A, et al.
Publicado: (2009)

Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease
por: Alicic, Radica Z., et al.
Publicado: (2023)

Incretin hormones and the satiation signal
por: Holst, J J
Publicado: (2013)

Berberine Protects against NEFA-Induced Impairment of Mitochondrial Respiratory Chain Function and Insulin Signaling in Bovine Hepatocytes
por: Shi, Zhen, et al.
Publicado: (2018)

A Tale of Two Biomarkers: Untargeted (1)H NMR Metabolomic Fingerprinting of BHBA and NEFA in Early Lactation Dairy Cows
por: Luke, Timothy D. W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_813vs2m7rkb8hhicgq9ki5rm47